Emil Chuang
Chief Tech/Sci/R&D Officer en Intrinsic Medicine, Inc. .
Perfil
Emil Chuang is currently the Chief Medical Officer at Intrinsic Medicine, Inc. He previously held the same position at the same company.
Prior to that, he was the Global Head-Translational Research at Takeda Pharmaceutical Co., Ltd.
from 2016 to 2018.
From 2018 to 2020, he was the Vice President-Precision Medicine at Biora Therapeutics, Inc. Chuang completed his undergraduate degree at The University of Sydney.
Cargos activos de Emil Chuang
| Empresas | Cargo | Inicio |
|---|---|---|
Intrinsic Medicine, Inc.
 Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 01/09/2021 |
Antiguos cargos conocidos de Emil Chuang.
| Empresas | Cargo | Fin |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2020 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/06/2018 |
Formación de Emil Chuang.
| The University of Sydney | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Empresas privadas | 1 |
|---|---|
Intrinsic Medicine, Inc.
Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Commercial Services |
- Bolsa de valores
- Insiders
- Emil Chuang
